Hesperos, Inc. is a leader in efforts to characterize an individual's biology with Human-on-a-Chip microfluidic systems. Founders Michael L. Shuler and James J. Hickman have been at the forefront of every major scientific discovery in this realm, from individual organ-on-a-chip constructs to fully functional, interconnected multi-organsystems. With a mission to revolutionize toxicology testing as well as efficacy evaluation for drug discovery, the company has created pumpless platforms with serum-free cellular mediums that allow multi-organ system communication and integrated computational PKPD modeling of live physiological responses utilizing functional readouts from neurons, cardiac, muscle, barrier tissues and neuromuscular junctions as well as responses from liver, pancreas and barrier tissues.

Biotechnology

Life Sciences

Hesperos Inc.

James Kronauge

James J. Hickman

Nate Post

Zhanhe Liu (Kevin)

Walker Hagan

The Leadership Team at Hesperos Inc. is responsible for steering the strategic direction of the company, cultivating scientific innovation, and ensuring operational excellence. Comprising the Chief Executive Officer, Chief Scientist, and Principal Operations Analyst, the team synergizes expertise in business management, scientific research, and operations to advance Hesperos' mission of revolutionizing toxicology testing and drug efficacy evaluation using Human-on-a-Chip microfluidic systems.

Leadership Team

Research and Development

Engineering Team

Leadership Team

About

Team members

Other teams at Hesperos Inc.

Research and Development

Engineering Team